Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Kenvue Just IPO'd, but Is the Stock a Buy?


With its listing on the New York Stock Exchange on May 4 and the conclusion of its initial public offering (IPO) on May 8, Kenvue (NYSE: KVUE) is finally a separate entity from Johnson Johnson (NYSE: JNJ).

The IPO raised net proceeds of $4.2 billion, and it marks the birth of a new giant within the consumer health products industry. And that may bring new opportunities for investors, too.

But consumer health goods businesses aren't exactly known for being fast-growing, and Kenvue still has a lot to prove now that it's standing on its own. So will this stock be a good fit for your portfolio? Let's investigate. 

Continue reading


Source Fool.com

Like: 0
Share

Comments